What Researchers Did
Researchers planned a systematic review and meta-analysis to gather and analyze all available randomized controlled trials testing whether hyperbaric oxygen therapy (HBOT) can improve thinking and memory problems in people with Parkinson's disease.
What They Found
This is a protocol paper, no results are available yet. The review will search databases including PubMed and Cochrane Library for trials published up to April 2024. Results will be analyzed using RevMan 5.3 and Stata 15.0, with bias assessed by the Cochrane risk-of-bias tool.
What This Means for Canadian Patients
Parkinson's disease affects roughly 100,000 Canadians, and cognitive decline is one of its most disabling features. This review, once completed, will provide the clearest evidence yet on whether HBOT should be considered for Parkinson's-related cognitive impairment. Canadians with Parkinson's and their neurologists should watch for this review's publication.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a study protocol only, no actual patient data has been collected or analyzed yet, so no clinical conclusions can be drawn.